Hamzeh Al Qublan

Title: Hamzeh Al Qublan: Innovator in Multivalent Vaccine Development

Introduction

Hamzeh Al Qublan is a notable inventor based in Blacksburg, VA (US). He has made significant contributions to the field of vaccine development, particularly in creating innovative solutions for mycobacterial infections. His work is characterized by a commitment to advancing public health through scientific research and innovation.

Latest Patents

Hamzeh Al Qublan holds a patent for a multivalent vaccine designed for protection against mycobacterial infections. This vaccine expresses at least one heterologous antigen and serves as an environmentally safe bivalent vaccine. It is specifically engineered to provide protection against infections simultaneously. The multivalent vaccine comprises a strain transformed with a vector that expresses at least one antigen, which is codon optimized for the strain. Notably, the strain used is RB51 leuB, and the antigens include Ag85B, Rv2660c, and ESAT6. He has 1 patent to his name.

Career Highlights

Hamzeh Al Qublan is associated with Virginia Tech Intellectual Properties, Inc., where he continues to work on innovative projects. His research focuses on developing vaccines that are not only effective but also environmentally safe. His dedication to advancing vaccine technology has positioned him as a key figure in his field.

Collaborations

Throughout his career, Hamzeh has collaborated with talented individuals such as Sriranganathan Nammalwar and Garrett Smith. These collaborations have enhanced his research efforts and contributed to the development of groundbreaking vaccine technologies.

Conclusion

Hamzeh Al Qublan is a pioneering inventor whose work in multivalent vaccine development is making a significant impact in the fight against mycobacterial infections. His innovative approach and dedication to research exemplify the importance of scientific advancement in public health.